Markets › Super Investors › KIRAN MAZUMDAR SHAW
KS
KIRAN MAZUMDAR SHAW
IndividualDisclosed Indian equity holdings above the 1% filing threshold.
Disclosed value
₹21,043 Cr
Today
−₹152.3 Cr -0.72%
Companies
3
As of
31 Mar 2026
Returns vs NIFTY current basket, 1 year
This portfolio +17.0% NIFTY 50 -4.4%ahead of NIFTY by 21.4 pts
Today’s disclosed holdings valued back over the past year vs the NIFTY 50, rebased to 0%. Not a record of actual trades.
Sector allocation
Portfolio X-ray
Top-5 weight
100%
Wtd P/E
177.2
Wtd ROE
2.1%
Holdings
3
By market cap
Large 100% Mid 0% Small 0%
Holdings · 3
| Company▾ | Stake▾ | Value▼ | Today▾ | Q/Q▾ | P/E▾ | ROE▾ |
|---|---|---|---|---|---|---|
| Biocon Ltd BIOCON · Healthcare | 29.90% | ₹20,161 Cr | -0.70% | – | 182.9 | 1% |
| Narayana Hrudayalaya Ltd NH · Healthcare | 2.30% | ₹881.1 Cr | -1.14% | – | 47.5 | 20% |
| Syngene International Ltd SYNGENE · Healthcare | 0.01% | ₹1 Cr | -1.10% | – | 57.7 | 7% |
Stake history by quarter (%) increased trimmed
| Company | Mar '26 | Dec '25 | Sept '25 | Jun '25 |
|---|---|---|---|---|
| Biocon Ltd | 29.90 | 36.24 | 36.24 | 36.24 |
| Narayana Hrudayalaya Ltd | 2.30 | 2.30 | 2.30 | 2.30 |
| Syngene International Ltd | 0.01 | 0.01 | 0.01 | 1.00 |
Holdings are taken exactly as filed in public shareholding disclosures, shown only once a stake crosses the 1% disclosure threshold, so this is the holder’s large positions, not every holding. Value = disclosed shares × latest market price, so it moves daily while share counts update each quarter; “Q/Q” compares with the prior filing (pp = percentage points). Names are shown as filed and folded only for capitalisation and spacing, never different spellings; a common name could, in principle, represent more than one person. For information only, not investment advice.